De Merk Pharmaceutical Private Limited
About De Merk Pharmaceutical Private Limited
Data last updated:
De Merk Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2021PTC381822.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Khursheed Ahmad Dar and Khurshid Ahmad Wani.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Prem Gopal Mehra House No. 620 Sanjay Enclave Jahangirpuri Shalimarbag, Delhi, India – 110033.
Company details
Contact details
De Merk Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered AddressC/O Prem Gopal Mehra House No. 620 Sanjay Enclave Jahangirpuri Shalimarbag, Delhi, India – 110033
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of De Merk Pharmaceutical Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of De Merk Pharmaceutical Private Limited, buy the company report.
Board of directors of De Merk Pharmaceutical Private Limited
De Merk Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khursheed Ahmad Dar | Director | 02 Jun 2021 | 5 Years 5 Months | Current |
| Khurshid Ahmad Wani | Director | 06 Apr 2023 | 3 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving De Merk Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for De Merk Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for De Merk Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
De Merk Pharmaceutical Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Hidayat Ullah Mantoo ceased to be Director on 07 Apr 2023.
Frequently asked questions
De Merk Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 June 2021 (5+ years old) and is registered under CIN U24232DL2021PTC381822.
De Merk Pharmaceutical has 2 current directors:
- Khursheed Ahmad Dar - Director
- Khurshid Ahmad Wani - Director
The latest financial statements of De Merk Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of De Merk Pharmaceutical is U24232DL2021PTC381822. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
De Merk Pharmaceutical was incorporated on 02 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Hidayat Ullah Mantoo ceased to be Director on 07 Apr 2023. Javid Ahmad Ganai ceased to be Director on 07 Apr 2023. Khurshid Ahmad Wani was appointed as Director on 06 Apr 2023. De Merk Pharmaceutical has 4 board changes on record in total.
The registered office of De Merk Pharmaceutical is at CO Prem Gopal Mehra House No. 620 Sanjay Enclave Jahangirpuri Shalimarbag, Delhi, India – 110033.
De Merk Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
De Merk Pharmaceutical can be reached at its registered office: CO Prem Gopal Mehra House No. 620 Sanjay Enclave Jahangirpuri Shalimarbag, Delhi, India – 110033.
De Merk Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
